{
  "ticker": "OSL",
  "pdf_display_url": "https://www.asx.com.au/asx/v2/statistics/displayAnnouncement.do?display=pdf&idsId=02967805",
  "id": "02967805",
  "pages": 6,
  "price_sensitive": false,
  "date": "20250709",
  "time": "1348",
  "pdf_url": "https://announcements.asx.com.au/asxpdf/20250709/pdf/06lmyw391hd9t2.pdf",
  "summary": "### **Capital Raising Announcement Summary (Placement)**  \n- **Structure**: Placement of shares and attached options  \n- **Total Securities Issued**:  \n  - **Ordinary Shares (OSL)**: 17,271  \n  - **Attaching Options**: 17,271 (Exercise price: AUD 1.20, Expiry: 31-Jul-2027)  \n- **Issue Price**: AUD 1.158 per share  \n- **Proposed Issue Date**: 8-Aug-2025  \n- **Purpose**: Funding clinical trials, administration, and working capital.  \n- **Shareholder Approval**: Obtained at EGM on 8-Jul-2025 (director participation under SPP terms).  \n\n(No material timetable dates or cash balance disclosed.)",
  "usage": {
    "prompt_tokens": 2173,
    "completion_tokens": 162,
    "total_tokens": 2335,
    "prompt_tokens_details": null
  },
  "model": "deepseek/deepseek-chat-v3-0324:free",
  "processed_at": "2025-07-09T04:05:32.161729"
}